BSE filing, NSE: MAZDOCK. Summary written from the filing by ALFA Finder's alert engine.
Mazagon Dock Shipbuilders Ltd: key numbers
- Share price
- ₹1,732.80
- Market cap
- ₹69,898 Cr
- Revenue (annual)
- ₹13,006 Cr
- Net profit (annual)
- ₹2,583 Cr
- P/E (TTM)
- 28.5×Sector 52.2×
- Promoter holding
- 81.22%+0.00% QoQ
- FII holding
- 1.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mazagon Dock Shipbuilders Ltd
All →Mazagon Dock Shipbuilders Capital Structure Change
Mazagon Dock's board approved raising authorised share capital to 180 crore equity shares, subject to DIPAM consent. No fund-raise amount is stated.
Mazagon Dock Shipbuilders Investor Presentation: Key Takeaways
Q2/H1 FY27 deck: H1 consolidated revenue ₹5,389 Cr, PAT ₹1,202 Cr; order book ₹16,443 Cr as of 30 Sep 2026. No explicit guidance given.
Mazagon Dock Shipbuilders Dividend
Mazagon Dock set November 3, 2026 as the record date for its ₹5 interim dividend. Payment is due by November 26, 2026.
Mazagon Dock Shipbuilders Debt & Borrowing: ₹1,250 Cr
MDL board approved a Rs.1,250 Crore credit facility with SBI for back-to-back SBLCs favouring subsidiary Colombo Dockyard PLC. The guarantee exposes MDL to contingent liability if the subsidiary defaults.
- Value
- ₹1,250 Cr
Mazagon Dock Shipbuilders Q2 FY27 Results: Net Profit ₹346.4 Cr, Down 53.8% YoY
Mazagon Dock Shipbuilders Ltd reported revenue from operations of ₹2,446 Cr (-16.5% YoY) and net profit of ₹346.4 Cr (-53.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹346.4 Cr · -53.8% YoY
Mazagon Dock Shipbuilders Board Meeting Date
Mazagon Dock Shipbuilders Limited will hold a board meeting on 27 October 2026 to consider its unaudited financial results and a potential interim dividend.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.